Microsoft’s Azure-based AI development and deployment platform shines with a strong selection of models and agent types and ...
Agilent Technologies (A) is back in focus after receiving U.S. FDA approval for its PD-L1 IHC 22C3 pharmDx assay as a companion diagnostic for esophageal and gastroesophageal junction carcinoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results